Long non-coding RNAs involved in gynecological cancer

International Journal of Gynecological Cancer

Volumn 24, Issue 7, 2014, Pages 1140-1145

  Zhao, Manyin ^a   Qiu, Yiran ^a   Yang, Baicai ^a   Sun, Li ^a   Hei, Kaiwen ^a   Du, Xue ^a   Li, Yongmei ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Gynecological cancer; IncRNAs; Oncogene; Tumor suppressive lncRNAs

Indexed keywords

LONG UNTRANSLATED RNA;

CARCINOGENESIS; DISEASE COURSE; FEMALE; FEMALE GENITAL TRACT TUMOR; GENETICS; HUMAN; ONCOGENE; PATHOLOGY; PHYSIOLOGY; TUMOR SUPPRESSOR GENE;

CARCINOGENESIS; DISEASE PROGRESSION; FEMALE; GENES, TUMOR SUPPRESSOR; GENITAL NEOPLASMS, FEMALE; HUMANS; ONCOGENES; RNA, LONG NONCODING;

EID: 84906880152     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0000000000000212     Document Type: Article

References (50)

1. An S, Song JJ. The coded functions of noncoding RNAs for gene regulation. Mol Cells. 2011;31:491-496.
2. Wilusz JE, Sunwoo H, Spector DL. Long non-coding RNAs: functional surprises from the RNA world. Genes Dev. 2009;23:1494-1504.
3. Lang JH, Ding XM. Characteristics and main questions in current diagnosis and treatment of gynecological cancer. Oncol Prog. 2006;4:2-6.
4. Stein LD. Human genome: end of the beginning. Nature. 2004;431:915-916.
5. Ponting CP, Belgard TG. Transcribed dark matter: meaning or myth? Hum Mol Genet. 2010;19:R162-R168.
6. Gutschner T, Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol. 2012;9:703-719.
7. Birney E, Stamatoyannopoulos JA, Dutta A, et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature. 2007;447:799-816.
8. Costa FF. Non-coding RNAs: meet thy masters. Bioessays. 2010;32:599-608.
9. Khachane AN, Harrison PM. Mining mammalian transcript data for functional long non-coding RNAs. PLoS One. 2010;5:e10316.
10. Taft RJ, Pang KC, Mercer TR, et al. Non-coding RNAs: regulators of disease. J Pathol. 2010;220:26-39.
11. Sana J, Faltejskova P, Svoboda M, et al. Novel classes of non-coding RNAs and cancer. J Transl Med. 2012;10:103.
12. Mercer TR, Dinger ME, Mattick JS. Long non-coding into functions. Nat Rev Genet. 2009;10:155-159.
13. Costa FF. Non-coding RNAs: lost in translation? Gene. 2007;386:1-10.
14. Gibb EA, Vucic EA, Enfield KS, et al. Human cancer long non-coding RNA transcriptomes. PLoS One. 2011;6:e25915.
15. Gibb EA, Enfield KS, Stewart GL, et al. Long non-coding RNAs are expressed in oral mucosa and altered in oral premalignant lesions. Oral Oncol. 2011;47:1055-1061.
16. Tufarelli C, Stanley JA, Garrick D, et al. Transcription of antisense RNA leading to gene silencing and methylation as a novel cause of human genetic disease. Nat Genet. 2003;34:157-165.
17. Faghihi MA, Modarresi F, Khalil AM, et al. Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Nat Med. 2008;14:723-730.
18. Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell. 2009;136:29-41.
19. Hauptman N, Glavač D. Long non-coding RNA in cancer. Int J Mol Sci. 2013;14:4655-4669.
20. Silva JM, Boczek NJ, Berres MW, et al. LSINCT5 is over expressed in breast and ovarian cancer and affects cellular proliferation. RNA Biol. 2011;8:496-505.
21. Ji P, Diederichs S, Wang W, et al. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene. 2003;22:8031-8041.
22. Yang F, Zhang L, Huo XS. Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans. Hepatology. 2011;54:1679-1689.
23. Wang XS, Zhang Z, Wang HC, et al. Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma. Clin Cancer Res. 2006;12:4851-4858.
24. Gupta RA, Shah N, Wang KC, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature. 2010;464:1071-1076.
25. Wang F, Li X, Xie X, et al. UCA1, a non-protein-coding RNA up-regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion. FEBS Lett. 2008;582:1919-1927.
26. Fang Z, Wu L, Wang L, et al. Increased expression of the long non-coding RNA UCA1 in tongue squamous cell carcinomas: a possible correlation with cancer metastasis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2014;117:89-95.
27. Wang Y, Chen W, Yang C, et al. Long non-coding RNA UCA1a (CUDR) promotes proliferation and tumorigenesis of bladder cancer. Int J Oncol. 2012;41:276-284.
28. Rorive FS, Biskri L, Fossion C, et al. RTPCR-based UCA1 expression detection in urine samples as non-invasive reliable method for urothelial cancer diagnosis. EJC Suppl. 2009;7:28-29.
29. Liu SP, Yang JX, Cao DY, et al. Identification of differentially expressed long non-coding RNAs in human ovarian cancer cells with different metastatic potentials. Cancer Biol Med. 2013;10:138-141.
30. Yang C, Li X, Wang Y, et al. Long non-coding RNA UCA1 regulated cell cycle distribution via CREB through PI3-K dependent pathway in bladder carcinoma cells. Gene. 2012;496:8-16.
31. Wu W, Zhang S, Li X, et al. Ets-2 regulates cell apoptosis via the Akt pathway, through the regulation of urothelial cancer associated 1, a long non-coding RNA, in bladder cancer cells. PLoS One. 2013;8:73920.
32. Fan Y, Shen B, Tan M, et al. Long non-coding RNA UCA1 increases chemoresistances of bladder cancer cells by regulating Wnt signaling. FEBS J. 2014;281:1750-1758.
33. Liu XH, Liu ZL, Sun M, et al. The long non-coding RNA HOTAIR indicates a poor prognosis and promotes metastasis in non-small cell lung cancer. BMC Cancer. 2013;13:464.
34. Sørensen KP, Thomassen M, Tan Q, et al. Long non-coding RNA HOTAIR is an independent prognostic marker of metastasis in estrogen receptor-positive primary breast cancer. Breast Cancer Res Treat. 2013;142:529-536.
35. Geng YJ, Xie SL, Li Q, et al. Large intervening non-coding RNA HOTAIR is associated with hepatocellular carcinoma progression. J Int Med Res. 2011;39:2119-2128.
36. Yang Z, Zhou L, Wu LM, et al. Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation. Ann Surg Oncol. 2011;18:243-250.
37. Endo H, Shiroki T, Nakagawa T, et al. Enhanced expression of long non-coding RNA HOTAIR is associated with the development of gastric cancer. PLoS One. 2013;8:e77070.
38. Kogo R, Shimamura T, Mimori K, et al. Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res. 2011;71:6320-6326.
39. He X, Bao W, Li X, et al. The long non-coding RNA HOTAIR is upregulated in endometrial carcinoma and correlates with poor prognosis. Int J Mol Med. 2014;33:325-332.
40. Chen FJ, Sun M, Li SQ, et al. Upregulation of the long non-coding RNA HOTAIR promotes esophageal squamous cell carcinoma metastasis and poor prognosis. Mol Carcinog. 2013;52:908-915.
41. Zhang JX, Han L, Bao ZS, et al. HOTAIR, a cell cycle-associated long noncoding RNA and a strong predictor of survival, is preferentially expressed in classical and mesenchymal glioma. Neuro Oncol. 2013;15:1595-1603.
42. Tsai MC, Manor O, Wan Y, et al. Long noncoding RNA as modular scaffold of histone modification complexes. Science. 2010;329:689-693.
43. Ge XS, Ma HJ, Zheng XH, et al. HOTAIR, a prognostic factor in esophageal squamous cell carcinoma, inhibits WIF-1 expression and activates Wnt pathway. Cancer Sci. 2013;104:1675-1682.
44. Zhang X, Zhou Y, Mehta KR, et al. A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells. J Clin Endocrinol Metab. 2003;88:5119-5126.
45. Mourtada-Maarabouni M, Pickard MR, Hedge VL, et al. GAS5, a non-protein-coding RNA, controls apoptosis and is down regulated in breast cancer. Oncogene. 2009;28:195-208.
46. Qin R, Chen Z, Ding Y, et al. Long non-coding RNA MEG3 inhibits the proliferation of cervical carcinoma cells through the induction of cell cycle arrest and apoptosis. Neoplasma. 2013;60:486-492.
47. Lu KH, Li W, Liu XH, et al. Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression. BMC Cancer. 2013;13:461.
48. Zhao J, Zhang X, Zhou Y, et al. Cyclic AMP stimulates MEG3 gene expression in cells through a cAMP-response element (CRE) in the MEG3 proximal promoter region. Int J Biochem Cell Biol. 2006;38:1808-1820.
49. Wrana JL. H19, a tumour suppressing RNA? Bioessays. 1994;16:89-90.
50. Lanz RB, Chua SS, Barron N, et al. Steroid receptor RNA activator stimulates proliferation as well as apoptosis in vivo. Mol Cell Biol. 2003;23:7163-7176.